| Bioactivity | Zilganersen sodium is a glial fibrillary acidic protein (GFAP) inhibitor. Zilganersen sodium can be used in Alexander disease (AxD) research[1][2]. |
| Name | Zilganersen sodium |
| CAS | 2305355-64-8 |
| Formula | C230H301N67O127P19S13Na19 |
| Molar Mass | 7478.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Helm J, et al. Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases. Pharmaceutics. 2022 Aug 16;14(8):1708. |
Zilganersen sodium
CAS: 2305355-64-8 F: C230H301N67O127P19S13Na19 W: 7478.40
Zilganersen sodium is a glial fibrillary acidic protein (GFAP) inhibitor. Zilganersen sodium can be used in Alexander di
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.